Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9342 |
High Similarity |
NPD1934 |
Approved |
0.9032 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.891 |
High Similarity |
NPD2801 |
Approved |
0.8816 |
High Similarity |
NPD1511 |
Approved |
0.8797 |
High Similarity |
NPD3882 |
Suspended |
0.8765 |
High Similarity |
NPD6166 |
Phase 2 |
0.8765 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8765 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8701 |
High Similarity |
NPD1512 |
Approved |
0.8554 |
High Similarity |
NPD7074 |
Phase 3 |
0.8543 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD3817 |
Phase 2 |
0.8494 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8487 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8447 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8438 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8438 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8434 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8303 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8289 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8284 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8282 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.828 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.825 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.821 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8187 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.816 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8117 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8101 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8039 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8026 |
Intermediate Similarity |
NPD943 |
Approved |
0.8025 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7965 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7952 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7908 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7881 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7824 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7811 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7798 |
Intermediate Similarity |
NPD919 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7719 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7717 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7707 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7658 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7607 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7597 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7514 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2344 |
Approved |
0.75 |
Intermediate Similarity |
NPD37 |
Approved |
0.75 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7468 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7457 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7417 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7356 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7348 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD920 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7238 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7238 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7186 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7128 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7127 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7127 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7119 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7118 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD1470 |
Approved |
0.711 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7074 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7065 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7048 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7032 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7031 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7031 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7027 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7005 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7005 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3764 |
Approved |
0.6988 |
Remote Similarity |
NPD2654 |
Approved |
0.6983 |
Remote Similarity |
NPD2403 |
Approved |
0.6975 |
Remote Similarity |
NPD6355 |
Discontinued |
0.697 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6957 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD17 |
Approved |
0.6947 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7003 |
Approved |
0.6943 |
Remote Similarity |
NPD3450 |
Approved |
0.6943 |
Remote Similarity |
NPD3452 |
Approved |
0.694
|
Remote Similarity |
NPD6104 |
Discontinued |